戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  organ transplantation and two had undergone autologous bone marrow transplantation.
2  also been a concern in patients who undergo autologous bone marrow transplantation.
3 contribute to relapse in patients undergoing autologous bone marrow transplantation.
4 ts were randomized to receive cytokine-naive autologous bone marrow transplantation (ABMT) (n = 46) o
5  or to high-dose CPB chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) and periph
6 y and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation (ABMT) for MCL in
7 y and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation (ABMT) in patient
8              To those severely ill patients, autologous bone marrow transplantation (aBMT) is applied
9 IXY321 following high-dose therapy (HDT) and autologous bone marrow transplantation (ABMT) was conduc
10 based induction chemotherapy with or without autologous bone marrow transplantation (ABMT) with or wi
11 rome (MDS) has been well-described following autologous bone marrow transplantation (ABMT), the risk
12 intensive consolidation chemotherapy (CC) or autologous bone marrow transplantation (ABMT).
13 lidation was with intensive chemotherapy and autologous bone marrow transplantation (ABMT).
14 ve multimodality therapy and, in some cases, autologous bone marrow transplantation (ABMT).
15 peutically useful for HSPC collection before autologous bone marrow transplantation (ABMT).
16 chromosomal rearrangement who have undergone autologous bone marrow transplantation (ABMT).
17 m2), and carboplatin (800 mg/m2) (CTCb) with autologous bone marrow transplantation (ABMT).
18 undergoing high-dose chemotherapy (HDCT) and autologous bone marrow transplantation (ABMT).
19  outcomes in patients with cancer undergoing autologous bone marrow transplantation (ABMT).
20 ioning of patients undergoing treatment with autologous bone marrow transplantation (ABMT).
21 of disease and as a therapeutic component of autologous bone marrow transplantation (aBMT).
22 adiation conditioning regimens combined with autologous bone marrow transplantation, adoptively trans
23 ytotoxic T (Tc1) or Tc17 cells combined with autologous bone marrow transplantation after total body
24 ing high-dose chemotherapy, those undergoing autologous bone marrow transplantation, and those underg
25 ecade in defining the role of allogeneic and autologous bone marrow transplantation as consolidation
26  received myeloablative therapy supported by autologous bone marrow transplantation as consolidation
27 vested cells of patients who were undergoing autologous bone marrow transplantation as part of a high
28 side, and cyclophosphamide (CEC) followed by autologous bone marrow transplantation (AuBMT) was inves
29 platin, etoposide, and cyclophosphamide with autologous bone marrow transplantation (AuBMT) was inves
30                            For many cancers, autologous bone marrow transplantation (BMT) achieves a
31  a novel technique, from children undergoing autologous bone marrow transplantation (BMT) for cancer
32 roved marrow purging protocols are needed in autologous bone marrow transplantation (BMT) to achieve
33               Mixed-breed dogs had undergone autologous bone marrow transplantation (BMT) with stem c
34  (CR) following conventional chemotherapy or autologous bone marrow transplantation (BMT).
35             All patients were ineligible for autologous bone marrow transplantation due to overt meta
36                                              Autologous bone marrow transplantation has been performe
37 moradiotherapy and immunomagnetically purged autologous bone marrow transplantation has been shown to
38     Treatment with myeloablative therapy and autologous bone marrow transplantation improved event-fr
39 to "purge" autografts in patients undergoing autologous bone marrow transplantation in an effort to d
40 eering the use of high-dose chemotherapy and autologous bone marrow transplantation in patients with
41                                 The value of autologous bone marrow transplantation in the treatment
42 he immunosuppressive drug cyclosporine after autologous bone marrow transplantation induces a systemi
43 dren with AML in first remission with either autologous bone marrow transplantation or intensive chem
44 nistering high-dose chemotherapy followed by autologous bone marrow transplantation or peripheral blo
45 uppressive drug cyclosporine after syngeneic/autologous bone marrow transplantation paradoxically eli
46 eripheral-blood stem-cell transplantation or autologous bone marrow transplantation rescue as initial
47 ive chemotherapy or preparatory regimens for autologous bone marrow transplantation should prevent p5
48 ioimmunotherapy and chemotherapy followed by autologous bone marrow transplantation, the use of radio
49                                  We compared autologous bone marrow transplantation with intensive co
50 nd total-body irradiation (TBI) supported by autologous bone marrow transplantation, with the marrow

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。